Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
出版年份 2023 全文链接
标题
Combinatorial immunotherapy with gemcitabine and ex vivo-expanded NK cells induces anti-tumor effects in pancreatic cancer
作者
关键词
-
出版物
Scientific Reports
Volume 13, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2023-05-11
DOI
10.1038/s41598-023-34827-z
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- NK cell-based cancer immunotherapy: from basic biology to clinical development
- (2021) Sizhe Liu et al. Journal of Hematology & Oncology
- Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2021) Hyuna Sung et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Pancreatic cancer: A review of epidemiology, trend, and risk factors
- (2021) Jian-Xiong Hu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Pancreatic Cancer and Immunotherapy: A Clinical Overview
- (2021) Florentine E. F. Timmer et al. Cancers
- Ex vivo expanded allogeneic natural killer cells have potent cytolytic activity against cancer cells through different receptor-ligand interactions
- (2021) Daun Jung et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Anti-Tumor Activity of Expanded PBMC-Derived NK Cells by Feeder-Free Protocol in Ovarian Cancer
- (2021) Minhua Chen et al. Cancers
- Low-Dose Gemcitabine Treatment Enhances Immunogenicity and Natural Killer Cell-Driven Tumor Immunity in Lung Cancer
- (2020) Xin Zhang et al. Frontiers in Immunology
- BL-8040, a CXCR4 antagonist, in combination with pembrolizumab and chemotherapy for pancreatic cancer: the COMBAT trial
- (2020) Bruno Bockorny et al. NATURE MEDICINE
- A Phase 2 Study of Allogeneic GM-CSF Transfected Pancreatic Tumor Vaccine (GVAX) with Ipilimumab as Maintenance Treatment for Metastatic Pancreatic Cancer
- (2020) Annie A. Wu et al. CLINICAL CANCER RESEARCH
- PET imaging of the natural killer cell activation receptor NKp30
- (2020) Travis M. Shaffer et al. JOURNAL OF NUCLEAR MEDICINE
- Effect of adoptive T-cell immunotherapy on immunological parameters and prognosis in patients with advanced pancreatic cancer
- (2020) Tatsuo Kumai et al. CYTOTHERAPY
- Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures
- (2019) May Sabry et al. PLoS One
- Defective Localization With Impaired Tumor Cytotoxicity Contributes to the Immune Escape of NK Cells in Pancreatic Cancer Patients
- (2019) Seon Ah Lim et al. Frontiers in Immunology
- Progressive Impairment of NK Cell Cytotoxic Degranulation Is Associated With TGF-β1 Deregulation and Disease Progression in Pancreatic Cancer
- (2019) Eunsung Jun et al. Frontiers in Immunology
- IL-27 enhances IL-15/IL-18-mediated activation of human natural killer cells
- (2019) Yeon Ho Choi et al. Journal for ImmunoTherapy of Cancer
- Cryopreserved Human Natural Killer Cells Exhibit Potent Antitumor Efficacy against Orthotopic Pancreatic Cancer through Efficient Tumor-Homing and Cytolytic Ability
- (2019) Oh et al. Cancers
- Small Bowel Adenocarcinoma, Version 1.2020, NCCN Clinical Practice Guidelines in Oncology
- (2019) Al B. Benson et al. Journal of the National Comprehensive Cancer Network
- Pancreatic ductal adenocarcinoma: biological hallmarks, current status, and future perspectives of combined modality treatment approaches
- (2019) Michael Orth et al. Radiation Oncology
- Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment
- (2017) Mao Lin et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Boosting Natural Killer Cell-Based Immunotherapy with Anticancer Drugs: a Perspective
- (2017) Loredana Cifaldi et al. TRENDS IN MOLECULAR MEDICINE
- An important discovery on combination of irreversible electroporation and allogeneic natural killer cell immunotherapy for unresectable pancreatic cancer
- (2017) Mao Lin et al. Oncotarget
- KRAS: The Critical Driver and Therapeutic Target for Pancreatic Cancer
- (2017) Andrew M. Waters et al. Cold Spring Harbor Perspectives in Medicine
- The Molecular Mechanism of Natural Killer Cells Function and Its Importance in Cancer Immunotherapy
- (2017) Sourav Paul et al. Frontiers in Immunology
- Expansion of cytotoxic natural killer cells using irradiated autologous peripheral blood mononuclear cells and anti-CD16 antibody
- (2017) Hong-Rae Lee et al. Scientific Reports
- Administration of Gemcitabine After Pancreatic Tumor Resection in Mice Induces an Antitumor Immune Response Mediated by Natural Killer Cells
- (2016) Engin Gürlevik et al. GASTROENTEROLOGY
- Locally Advanced, Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline
- (2016) Edward P. Balaban et al. JOURNAL OF CLINICAL ONCOLOGY
- Anti-ovarian tumor response of donor peripheral blood mononuclear cells is due to infiltrating cytotoxic NK cells
- (2016) Veethika Pandey et al. Oncotarget
- Gemcitabine inhibits immune escape of pancreatic cancer by down regulating the soluble ULBP2 protein
- (2016) Xiansheng Lin et al. Oncotarget
- Xanthine oxidoreductase is required for genotoxic stress-induced NKG2D ligand expression and gemcitabine-mediated antitumor activity
- (2016) Xiulong Xu et al. Oncotarget
- Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2015) M. Ducreux et al. ANNALS OF ONCOLOGY
- Gene-mediated cytotoxic immunotherapy as adjuvant to surgery or chemoradiation for pancreatic adenocarcinoma
- (2015) Laura K. Aguilar et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Low-dose gemcitabine induces major histocompatibility complex class I-related chain A/B expression and enhances an antitumor innate immune response in pancreatic cancer
- (2015) Tomoharu Miyashita et al. CLINICAL AND EXPERIMENTAL MEDICINE
- Ascorbic acid promotes proliferation of natural killer cell populations in culture systems applicable for natural killer cell therapy
- (2015) Mirelle J.A.J. Huijskens et al. CYTOTHERAPY
- Erlotinib enhances the CIK cell-killing sensitivity of lung adenocarcinoma A549 cells
- (2015) J.Z. Mei et al. GENETICS AND MOLECULAR RESEARCH
- Contrasting Effects of the Cytotoxic Anticancer Drug Gemcitabine and the EGFR Tyrosine Kinase Inhibitor Gefitinib on NK Cell-Mediated Cytotoxicity via Regulation of NKG2D Ligand in Non-Small-Cell Lung Cancer Cells
- (2015) Riki Okita et al. PLoS One
- Phase II clinical trial of ex vivo-expanded cytokine-induced killer cells therapy in advanced pancreatic cancer
- (2014) Moon Jae Chung et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Therapeutic Advances in Pancreatic Cancer
- (2013) Andrew Scott Paulson et al. GASTROENTEROLOGY
- ADAM15 is involved in MICB shedding and mediates the effects of gemcitabine on MICB shedding in PANC-1 pancreatic cancer cells
- (2013) XIAOHUI DUAN et al. Molecular Medicine Reports
- Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
- (2013) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Clinical Grade Purification and Expansion of NK Cell Products for an Optimized Manufacturing Protocol
- (2013) Ulrike Koehl et al. Frontiers in Oncology
- Major histocompatibility complex class I-related chain A/B (MICA/B) expression in tumor tissue and serum of pancreatic cancer: Role of uric acid accumulation in gemcitabine-induced MICA/B expression
- (2011) Xiulong Xu et al. BMC CANCER
- Anti-tumour activity of afatinib, an irreversible ErbB family blocker, in human pancreatic tumour cells
- (2011) N Ioannou et al. BRITISH JOURNAL OF CANCER
- Susceptibility to natural killer cell-mediated lysis of colon cancer cells is enhanced by treatment with epidermal growth factor receptor inhibitors through UL16-binding protein-1 induction
- (2011) Jae-Ho Bae et al. CANCER SCIENCE
- FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
- (2011) Thierry Conroy et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activating and inhibitory receptors of natural killer cells
- (2010) Hollie J Pegram et al. IMMUNOLOGY AND CELL BIOLOGY
- The anatomic location of pancreatic cancer is a prognostic factor for survival
- (2008) Avo Artinyan et al. HPB
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now